摩洛哥哮喘：医院单位报告病例特征的回顾性分析
摘要
的哮喘病例的特征。2019年在SMRHC的肺科和儿科进行了回顾性分析。作为数据支持，使用了报告记录和数据收
集工作表。今年报告了141例。最高频率出现在2月（21.9%）和4月（26.6%）。男性和女性都受到影响（性别比男性
/女性=0.98）。哮喘患者的平均年龄为40.7±25.1岁。大多数病例来自在SMRHC就诊方便的地区。为了获得更准确
的知识并为研究做出贡献，应就该主题进行相关研究。我们希望，我们的研究结果将作为未来研究的基础，以根据
WHO和GINA指南改进病例登记系统（数字支持）和升级患者数据。
关键词
全文:
PDF参考
[1] Ait-Khaled, N., Odhiambo, J., Pearce, N., Adjoh, K.
S., Maesano, I. A., Benhabyles, B., Bouhayad, Z., Bahati, E.,
Camara, L., Catteau, C., El Sony, A., Esamai, F. O., Hypolite,
I. E., Melaku, K., Musa, O. A., Ng'ang'a, L., Onadeko, B.
O., Saad, O., Jerray, M., … Zar, H. J. (2007). Prevalence of
symptoms of asthma, rhinitis, and eczema in 13- to 14-yearold children in Africa: The International Study of Asthma and
Allergies in Childhood Phase III: ISAAC Phase III in Africa.
Allergy, 62(3), 247–258. https://doi.org/10.1111/j.1398-
9995.2007.01325.x
[2] Alaoui Yazidi, A., & Bartal, M. (2000). Prevalence of
sensitization to olive pollen determined by skin prick test in
Morocco. A multicentric study. [In French]. Revue Française
d’Allergologie et d’Immunologie Clinique, 40(4), 481–
488. https://doi.org/10.1016/S0335-7457(00)80089-1
[3] Asher, M. I., Montefort, S., Björkstén, B., Lai, C.
K., Strachan, D. P., Weiland, S. K., & Williams, H. (2006).
Worldwide time trends in the prevalence of symptoms of
asthma, allergic rhinoconjunctivitis, and eczema in childhood:
ISAAC Phases One and Three repeat multicountry crosssectional surveys. The Lancet, 368(9537), 733–743. https://
doi.org/10.1016/S0140-6736(06)69283-0
[4] Beasley, R. (1998). Worldwide variation in the
prevalence of symptoms of asthma, allergic rhinoconjunctivitis,
and atopic eczema: ISAAC. The Lancet, 351(9111), 1225–
1232. https://doi.org/10.1016/S0140-6736(97)07302-9
[5] Benjelloun, A., Ait Nasser, K., Janah, H., Benchanna,
R., & Bouchentouf, R. (2021). Particularity of asthmatic
patients in the Sahara: Example of the Guelmim Oued Noun
region, Morocco. [In French]. Revue Française d’Allergologie,
61(3), 177–183. https://doi.org/10.1016/j.reval.2020.10.001
[6] Bouayad, Z., Aichane, A., Afif, A., Benouhoud, N.,
Trombati, N., Chan-Yeung, M., & Aït-Khaled, N. (2006).
Prevalence and trend of selfreported asthma and other allergic
disease symptoms in Morocco: ISAAC phase I and III. The
International Journal of Tuberculosis and Lung Disease: The
Official Journal of the International Union Against Tuberculosis
and Lung Disease, 10(4), 371–377
[7] Bouchriti, Y., Elghazali, O., Kharbach, A., Gougueni,
H., Haddou, M. A., & Achbani, A. (2021). Characteristics of
Patients with Asthma and Asthma Control: A Retrospective
Analysis of Reported Data from Primary Healthcare Centers
in Agadir city, Morocco (2013 - 2019). Journal of Clinical
and Experimental Investigations, 12(2), em00766. https://doi.
org/10.29333/jcei/9566
[8] Carvajal-Urueña, I., García-Marcos, L., BusquetsMonge, R., Morales Suárez-Varela, M., García de
Andoin, N., Batlles-Garrido, J., BlancoQuirós, A., LópezSilvarrey, A., García-Hernández, G., Guillén-Grima, F.,
González-Díaz, C., & Bellido-Blasco, J. (2005). Geographic
Variation in the Prevalence of Asthma Symptoms in Spanish
Children and Adolescents. International Study of Asthma and
Allergies in Childhood (ISAAC) Phase 3, Spain. Archivos de
Bronconeumología ((English Edition)), 41(12), 659–666.
https://doi.org/10.1016/S1579-2129(06)60333-9
[9] CDC. (2016). Dean AG, Arner TG, Sunki GG,
Friedman R, Lantinga M, Sangam S, Zubieta JC, Sullivan
KM, Brendel KA, Gao Z, Fontaine N, Shu M, Fuller G, Smith
DC, Nitschke DA, and Fagan RF. Epi InfoTM, a database
and statistics program for public health professionals. CDC,
Atlanta, GA, USA, 2011. (7.2) [Computer software].
[10] Chaulet, P. (1989). Asthma and Chronic Bronchitis
in Africa: Evidence from Epidemiologic Studies. Chest, 96(3,
Supplement), 334S-339S. https://doi.org/10.1378/chest.96.3_
Supplement.334S
[11] D’Amato, G., Chong‐Neto, H. J., Monge Ortega, O.
P., Vitale, C., Ansotegui, I., Rosario, N., Haahtela, T., Galan, C.,
Pawankar, R., Murrieta‐Aguttes, M., Cecchi, L., Bergmann,
C., Ridolo, E., Ramon, G., Gonzalez Diaz, S., D’Amato, M.,
& Annesi‐Maesano, I. (2020). The effects of climate change
on respiratory allergy and asthma induced by pollen and mold
allergens. Allergy, 75(9), 2219–2228. https://doi.org/10.1111/
all.14476
[12] Douwes, J., & Pearce, N. (2002). Asthma and
the westernization ‘package.’ International Journal of
Epidemiology, 31(6), 1098–1102. https://doi.org/10.1093/
ije/31.6.1098
[13] El Fadili, S., Batahar, S. A., Sajiai, H., Serhane,
H., & Amro, L. (2016). Évaluation du contrôle d’asthme
à Marrakech. Revue Française d’Allergologie, 56(3), 323.
https://doi.org/10.1016/j.reval.2016.02.179
[14] El Ftouh, M., Yassine, N., Benkheder, A., Bouacha,
H., Nafti, S., Taright, S., Fakhfakh, H., Ali-Khoudja, M.,
Texier, N., & El Hasnaoui, A. (2009). Paediatric asthma in
North Africa: The Asthma Insights and Reality in the Maghreb
(AIRMAG) study. Respiratory Medicine, 103, S21–S29.
https://doi.org/10.1016/S0954-6111(09)70024-1
[15] GINA. (2021). Global Initiative for Asthma. Global
Strategy for Asthma Management and Prevention, 2021.
Available from: www.ginasthma.org
[16] Ketfi, A., Benchia, S., Khaldi, F., & Gharnaout, M.
(2018). Contrôle de l’asthme en consultations spécialisées.
Revue des Maladies Respiratoires, 35, A82. https://doi.
org/10.1016/j.rmr.2017.10.175
[17] Lake, I. R., Jones, N. R., Agnew, M., Goodess, C.
M., Giorgi, F., Hamaoui-Laguel, L., Semenov, M. A., Solomon,
F., Storkey, J., Vautard, R., & Epstein, M. M. (2017). Climate
Change and Future Pollen Allergy in Europe. Environmental
Health Perspectives, 125(3), 385–391. https://doi.
org/10.1289/EHP173
[18] Masoli, M., Fabian, D., Holt, S., Beasley, R., &
Global Initiative for Asthma (GINA) Program. (2004). The
global burden of asthma: Executive summary of the GINA
Dissemination Committee Report. Allergy, 59(5), 469–478.
https://doi.org/10.1111/j.1398-9995.2004.00526.x
[19] Michaels, R. A. (2017). Environmental Moisture,
Molds, and Asthma— Emerging Fungal Risks in the Context of
Climate Change. Environmental Claims Journal, 29(3), 171–
193. https://doi.org/10.1080/10406026.2017.1345521
[20] Nafti, S., Taright, S., El Ftouh, M., Yassine, N.,
Benkheder, A., Bouacha, H., Fakhfakh, H., Ali-Khoudja, M.,
Texier, N., & El Hasnaoui, A. (2009). Prevalence of asthma in
North Africa: The Asthma Insights and Reality in the Maghreb
(AIRMAG) study. Respiratory Medicine, 103, S2–S11. https://
doi.org/10.1016/S0954-6111(09)70022-8
[21] Nejjari, R., Elaissaoui, Y., Tebaa, A., & Rachida,
S. (2019). 5PSQ-091 Asthma in the Moroccan population.
Section 5: Patient Safety and Quality Assurance, A243.2-
A243. https://doi.org/10.1136/ejhpharm-2019-eahpconf.524
[22] Pearce, N., Aït-Khaled, N., Beasley, R., Mallol,
J., Keil, U., Mitchell, E., & Robertson, C. (2007). Worldwide
trends in the prevalence of asthma symptoms: Phase III of
the International Study of Asthma and Allergies in Childhood
(ISAAC). Thorax, 62(9), 758–766. https://doi.org/10.1136/
thx.2006.070169
[23] Sadeq, M., Abouqal, R., & ElMarnissi, A. (2015).
Secular trends in consultations for asthma in early childhood,
the 16 administrative regions of Morocco, 2004–2012. BMC
Public Health, 15(1), 905. https://doi.org/10.1186/s12889-
015-2262-8
[24] Urrutia, I., Aguirre, U., Sunyer, J., Plana, E.,
Muniozguren, N., Martínez-Moratalla, J., Payo, F.,
Maldonado, J. A., & Anto, J. M. (2007). Changes in the
Prevalence of Asthma in the Spanish Cohort of the European
Community Respiratory Health Survey (ECRHS-II). Archivos
de Bronconeumología ((English Edition)), 43(8), 425–430.
https://doi.org/10.1016/S1579-2129(07)60098-6
[25] Vos, T., Lim, S. S., Abbafati, C., Abbas, K.
M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M.,
Abbastabar, H., Abd-Allah, F., Abdelalim, A., Abdollahi, M.,
Abdollahpour, I., Abolhassani, H., Aboyans, V., Abrams, E. M.,
Abreu, L. G., Abrigo, M. R. M., Abu-Raddad, L. J., Abushouk,
A. I., … Murray, C. J. L. (2020). Global burden of 369 diseases
and injuries in 204 countries and territories, 1990–2019: A
systematic analysis for the Global Burden of Disease Study
2019. The Lancet, 396(10258), 1204–1222. https://doi.
org/10.1016/S0140-6736(20)30925-9
[26] WHO. (2021, May 3). Asthma, Key facts. WHO.
https://www.who.int/news-room/fact- sheets/detail/asthma
[27] Yan, D.-C., Ou, L.-S., Tsai, T.-L., Wu, W.-F., &
Huang, J.-L. (2005). Prevalence and severity of symptoms
of asthma, rhinitis, and eczema in 13-to 14-year-old
children in Taipei, Taiwan. Annals of Allergy, Asthma &
Immunology, 95(6), 579–585. https://doi.org/10.1016/S1081-
1206(10)61022-8
Refbacks
- 当前没有refback。
数据库合作单位
